Figure 3.
Timeline of selected novel target clinical trials for NEPC. Border colors indicate phase of the clinical trial (phase I, purple; phase II, blue; and phase III, orange). Fill colors indicate the status of the study (white, active/recruiting; green, completed; red, terminated; grey, unknown status).